Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
Abstract
Clinical tools to guide in the appropriate treatment selection in immunoglobulin light chain (AL) amyloidosis are not well developed. We evaluated the response and outcome for various regimens at first-line treatment (n=681) and first progression (n=240) stratified by the immunoparesis status at diagnosis. Immunoparesis was assessed by the average relative difference of the uninvolved immunoglobulins, classifying patients into a negative average...
Paper Details
Title
Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
Published Date
Jun 16, 2016
Journal
Volume
101
Issue
9
Pages
1102 - 1109
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History